Paul R Edick - Net Worth and Insider Trading
Paul R Edick Net Worth
The estimated net worth of Paul R Edick is at least $8 Million dollars as of 2024-12-26. Paul R Edick is the See Remarks of Xeris Biopharma Holdings Inc and owns about 2,321,494 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $8 Million. Paul R Edick is also the Director of Iterum Therapeutics PLC and owns about 1,682 shares of Iterum Therapeutics PLC (ITRM) stock worth over $3,120. Details can be seen in Paul R Edick's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul R Edick has not made any transactions after 2023-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul R Edick
Paul R Edick Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul R Edick owns 7 companies in total, including Milestone Pharmaceuticals Inc (MIST) , Xeris Biopharma Holdings Inc (XERS) , and Iterum Therapeutics PLC (ITRM) among others .
Click here to see the complete history of Paul R Edick’s form 4 insider trades.
Insider Ownership Summary of Paul R Edick
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc | 2019-05-08 | director |
| XERS | Xeris Biopharma Holdings Inc | 2023-08-09 | director & See Remarks |
| ITRM | Iterum Therapeutics PLC | 2019-05-24 | director |
 | | 2018-06-08 | director |
| | 2018-02-13 | director |
| | 2017-07-03 | director |
| | 2012-01-19 | director |
Paul R Edick Latest Holdings Summary
Paul R Edick currently owns a total of 2 stocks. Among these stocks, Paul R Edick owns 2,321,494 shares of Xeris Biopharma Holdings Inc (XERS) as of August 9, 2023, with a value of $8 Million and a weighting of 99.96%. Paul R Edick also owns 1,682 shares of Iterum Therapeutics PLC (ITRM) as of August 23, 2018, with a value of $3,120 and a weighting of 0.04%.
Latest Holdings of Paul R Edick
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2023-08-09 | 2,321,494 | 3.46 | 8,020,762 |
| ITRM | Iterum Therapeutics PLC | 2018-08-23 | 1,682 | 1.86 | 3,120 |
Holding Weightings of Paul R Edick
Paul R Edick Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul R Edick has made a total of 8 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the acquisition of 10,000 shares on August 9, 2023, which cost Paul R Edick around $23,800.
According to the SEC Form 4 filings, Paul R Edick has made a total of 0 transactions in Iterum Therapeutics PLC (ITRM) over the past 5 years. The most-recent trade in Iterum Therapeutics PLC is the acquisition of 33 shares on August 23, 2018, which cost Paul R Edick around $5,220.
Insider Trading History of Paul R Edick
- 1
Paul R Edick Trading Performance
GuruFocus tracks the stock performance after each of Paul R Edick's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul R Edick is -7.7%. GuruFocus also compares Paul R Edick's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul R Edick within 3 months outperforms 5 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul R Edick's insider trading performs compared to the benchmark.
Performance of Paul R Edick
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.96 | | | | | |
| Relative Return to S&P 500(%) | 2.57 | | | | | |
Paul R Edick Ownership Network
Paul R Edick Owned Company Details
What does Milestone Pharmaceuticals Inc do?
Who are the key executives at Milestone Pharmaceuticals Inc?
Paul R Edick is the director of Milestone Pharmaceuticals Inc. Other key executives at Milestone Pharmaceuticals Inc include Chief Medical Officer David Bharucha , 10 percent owner Roderick Wong , and 10 percent owner Rtw Investments, Lp .
Milestone Pharmaceuticals Inc (MIST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Milestone Pharmaceuticals Inc (MIST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Milestone Pharmaceuticals Inc (MIST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Milestone Pharmaceuticals Inc (MIST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Milestone Pharmaceuticals Inc Insider Transactions
Paul R Edick Mailing Address
Above is the net worth, insider trading, and ownership report for Paul R Edick. You might contact Paul R Edick via mailing address: C/o Newlink Genetics Corp., 2503 South Loop Dr., Suite 5100, Ames Ia 50010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
